PRISCOLINE Drug Patent Profile
✉ Email this page to a colleague
When do Priscoline patents expire, and what generic alternatives are available?
Priscoline is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in PRISCOLINE is tolazoline hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tolazoline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRISCOLINE?
- What are the global sales for PRISCOLINE?
- What is Average Wholesale Price for PRISCOLINE?
Summary for PRISCOLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 3,816 |
| DailyMed Link: | PRISCOLINE at DailyMed |
US Patents and Regulatory Information for PRISCOLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | PRISCOLINE | tolazoline hydrochloride | INJECTABLE;INJECTION | 006403-005 | Feb 22, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
